Compound Summary
Zolantidine
Compound Information
Zolantidine
Compound Name: | Zolantidine |
Compound CID: | 91769 |
Synonyms: | Zolantidine Skf 95282 104076-38-2 SK&F-95282 UNII-M1108XAY01 More... |
Iupac Name: | N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,3-benzothiazol-2-amine |
InChI: | InChI=1S/C22H27N3OS/c1-4-13-25(14-5-1)17-18-8-6-9-19(16-18)26-15-7-12-23-22-24-20-10-2-3-11-21(20)27-22/h2-3,6,8-11,16H,1,4-5,7,12-15,17H2,(H,23,24) |
InChIKey: | KUBONGDXTUOOLM-UHFFFAOYSA-N |
Canonical Smiles: | C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC3=NC4=CC=CC=C4S3 |
Isomeric Smiles: | C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC3=NC4=CC=CC=C4S3 |
Molecular Weight: | 381.5 |
Molecular Formula: | C22H27N3OS |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Zolantidine
Molecular Weight: | 381.5 |
Molecular Formula: | C22H27N3OS |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 27 |
Complexity: | 432 |
Synonyms
Zolantidine
| Zolantidine | Zolantidine |
|---|---|
Zolantidine |
Skf 95282 |
104076-38-2 |
SK&F-95282 |
UNII-M1108XAY01 |
M1108XAY01 |
N-3-3-(piperidin-1-ylmethyl)phenoxypropyl-1,3-benzothiazol-2-amine |
SKF95282;SKF-95282;SKF 95282 |
104076-39-3 |
SKF-95282 |
SK&F 95282 |
2-Benzothiazolamine,N-3-3-(1-piperidinylmethyl)phenoxypropyl- |
2-(3-(3-(Piperidinomethyl)phenoxy)propylamino)benzothiazole |
Tocris-1070 |
N-3-3-(1-Piperidinylmethyl)phenoxypropyl-2-benzothiazolamine |
Lopac-S-5317 |
2-Benzothiazolamine, N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)- |
Lopac0_001245 |
CHEMBL419296 |
DTXSID6048460 |
SCHEMBL10400337 |
CHEBI:92158 |
ZINC2386778 |
MFCD01862676 |
CCG-205319 |
SDCCGSBI-0051212.P002 |
NCGC00015957-01 |
NCGC00015957-02 |
NCGC00015957-03 |
NCGC00015957-04 |
NCGC00015957-05 |
NCGC00024980-01 |
NCGC00024980-02 |
NCGC00024980-03 |
L000637 |
Q8073549 |
BRD-K08996725-313-01-7 |
2-3-3-(Piperidinomethyl)phenoxypropylaminobenzthiazole |
N-(3-(3-(Piperidin-1-ylmethyl)phenoxy)propyl)benzodthiazol-2-amine |
Experimental Data
Zolantidine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drosophila melanogaster | 200.000000000000000 | umol/L | 46.640000000000000 | 46.480000000000000 | -0.341300000000000 | NS | MALES | 33008901 | Inactive | ||||
| Drosophila melanogaster | 20.000000000000000 | umol/L | 46.240000000000000 | 47.650000000000000 | 3.065000000000000 | NS | FEMALES | 33008901 | Inactive |
Experimental Data Visualization
Zolantidine
Statistics Data
Zolantidine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Drosophila melanogaster | 3.065000000000000 | 1 | 2 |
Statistics Data Visualization
Zolantidine
